{"type":"rich","version":"1.0","provider_name":"Transistor","provider_url":"https://transistor.fm","author_name":"The Healthy Enterprise","title":"Transforming Pharma Consulting: The Fractional Model with Mary Hames","html":"<iframe width=\"100%\" height=\"180\" frameborder=\"no\" scrolling=\"no\" seamless src=\"https://share.transistor.fm/e/ffc006fc\"></iframe>","width":"100%","height":180,"duration":2961,"description":"In this conversation, Mary Hames, CEO and founder of BioLogic Pharma Solutions, discusses her journey in the biotech and pharmaceutical consulting industry. She explains the fractional model of consulting, which allows smaller companies to access expertise without the financial burden of hiring full-time staff. Mary shares her entrepreneurial journey, the importance of company culture, and the challenges of consulting in a dynamic environment. She also highlights the significance of trust in startups and her aspirations for the future of her company.\n00:00 Introduction to BioLogic Pharma Solutions\n03:01 The Fractional Model in Biotech Consulting\n06:00 Navigating Uncertainty in Drug Development\n09:04 Mary's Entrepreneurial Journey\n11:50 Vision for the Future of Biotech Consulting\n14:45 Challenges in Consulting and Growth\n17:57 The Importance of Trust in Entrepreneurship\n26:49 The Importance of Delegation in Business\n28:02 Navigating Client Acquisition and Marketing Strategies\n30:35 Effective Client Engagement and Presentation Techniques\n34:12 Understanding Market Dynamics and Client Feedback\n36:11 Identifying the Sweet Spot in the Drug Development Process\n39:25 Building a Flexible Workforce and Consultant Relationships\n40:19 Future Aspirations and Growth Strategies for the Company\n46:12 Reflections on the Entrepreneurial Journey\nGuest Information:\nGuest's Name: Mary Hames \nGuest's Title/Position: Founder & CEO\nGuest's Linkedin: https://www.linkedin.com/in/mary-hames-phd-biologicpharmasolutions/\nCompany / Affiliation: BioLogic Pharma Solutions https://biologicpharmasolutions.com/\nGuest's Bio: Mary Hames is a scientist-turned-strategic leader with over a decade of experience guiding biotech and pharma companies from breakthrough science to real-world impact. With deep expertise in neurology, rare diseases, and radiopharmaceuticals, Mary has held roles spanning R&D, medical affairs, diagnostics, and executive leadership. She specializes in translating complex science...","thumbnail_url":"https://img.transistorcdn.com/WKku9MQ84q-0q9Awqd5xdS4eoTolo1ocic6_1x8xlF0/rs:fill:0:0:1/w:400/h:400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9mMjI4/MDliNWYyM2MxYWFi/NTkwZmIwNzJkYjk2/YjliMy5qcGc.webp","thumbnail_width":300,"thumbnail_height":300}